Bird & Bird

Animal health giant Abbey Laboratories has fought off a challenge to its bid to register 'Virkill' as a trade mark for its disinfectant products, despite an IP Australia delegate finding the name was deceptively similar to its opponent's 'Virukill' mark.

A settlement has been reached in a dispute over more than $100 million in shares in AI data centre start-up Firmus Grid ahead of an expected $7 billion IPO, just days before the company's founders were due to give evidence in court.

The founders of AI data centre start-up Firmus Grid have been subpoenaed to give evidence in a dispute between former business partners Simon Raftery and Ben Madsen over $100 million in company shares, ahead of an expected $7 billion IPO.

The bankruptcy trustee for Dyldam Developments director Sam Fayad has raised concerns about upcoming sales of property in western Sydney, saying an $8 million loan secured against the real estate may be a "sham".

A judge has refused to set aside a deed of company arrangement passed by creditors of construction company Mercon, finding that the owners corporation of a 33-unit development has not proved the value of its $4.2 million claim. 

Abbey Animal Health has appealed its loss in a suit seeking to invalidate rival Virbac's patent for an antiparasitic drug.

Abbey Animal Health has managed only a “pyrrhic victory" in a patent case against rival Virbac over an antiparasitic drug, and must withdraw its Levamox Duo product from the market, a court has found.

Dyldam Developments' former boss Sam Fayad and his two sons have been ordered to pay over $50 million in a case by the liquidator of a special purpose vehicle claiming company funds were misused.

A liquidator has opened his case over the alleged misuse of funds by now defunct Dyldam Developments, as the court hears of “oddities” in financial records and the spaghetti-like structure of 157 interrelated entities.

White & Case has snapped up an IT and IP expert from Bird & Bird, citing the increasing need for technological expertise in M&A and private equity transactions.